Home » Topics » BioWorld Science

BioWorld Science
RSS

Inflammasome inhibition is promising antibacterial therapy

Dec. 13, 2018

MTH1 expression levels predict breast cancer prognosis

Dec. 13, 2018

"Noncoding" regions produce tumor antigens

Dec. 13, 2018

Tumor T cells mostly just rubbernecking

Dec. 13, 2018

FDA accepts IND for Sermonix's phase II trial of oral lasofoxifene in breast cancer

Dec. 12, 2018

Aeglea announces phase III plans for pegzilarginase in arginase 1 deficiency

Dec. 12, 2018

Vect-Horus enters research collaboration agreement with Janssen

Dec. 12, 2018

University of Michigan divulges lysine-specific histone demethylase 1A inhibitors

Dec. 12, 2018

RIP-1 inhibitors discovered at Denali Therapeutics

Dec. 12, 2018

Arcus Biosciences patents adenosine receptor A2A and/or A2B antagonists

Dec. 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...